Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.063 | 0.7 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.064 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.047 | 0.7 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |